Tri Locum Partners LP

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
19
Total value ($000)
$813,224
Net value change ($000)
+100,675 (14.1%)
New positions
5
Sold out positions
3
Turnover %
39.4%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/18/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 69,011 NEW
ELVN 43,986 NEW
AXSM 43,181 411.3%
VRTX 42,492 73.6%
LLY 34,958 61.5%
RVMD 28,433 NEW
JAZZ 23,433 78.1%
CYTK 16,527 NEW
ARGX 15,491 67.1%
DXCM 11,415 26.0%
Top Reduces (Value $000, Stocks/ETFs)
TMO -65,085 -100.0%
ASND -58,402 -100.0%
ISRG -51,565 -73.0%
NUVL -31,606 -100.0%
MDGL -17,409 -32.2%
UTHR -16,248 -38.9%
TEVA -5,450 -17.7%
DNTH -447 -3.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type